Full Text
Feasibility of Matching-Adjusted Indirect Comparison (MAIC) of Omalizumab (OMA) vs. Mepolizumab (Mepo) in Moderate-to-Severe Asthma

Abstract

Authors

R Ayyagari L Álvares F Mu V Hacking R Martinez JE Signorovitch

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×